🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Muscle Function Following Anterior Cruciate Ligament Reconstruction: Impaired Power Output in Physically Active Individuals

RecruitingNAAges 18 Years - 65 YearsAllCentre Hospitalier Metropole Savoie
NCT07765173 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to to determine the extent of the association between objective changes in the muscle function of the knee extensors (strength and power) and the function reported by the patient following ACL reconstruction surgery. The main questions it aims to answer is: \- Pre- and post-operative (6 months) changes in maximum knee extensor strength following ACL reconstruction, correlated with the IKDC-SKF score.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients requiring isolated or complex ACL reconstruction (combined with a meniscal injury) * Patients who are physically active (Tegner score ≥ 4) and wish to resume such activity. * Patients with no history of surgery on the ipsilateral knee (i.e., native knee). * Patients able to comply with the study procedures * Patients who have given their free and informed written consent, having been informed of the purpose of the study, its procedure and its risks. * Be affiliated to a social security scheme. Exclusion Criteria: * Patient with comprehension difficulties * Recurrent rupture of the ipsilateral ACL * Multi-ligament injuries (i.e., injury to the medial collateral ligament, lateral collateral ligament or posterior cruciate ligament)
💊

What it tests

  • assessment
📍

Where

1 site
Médipôle de Savoie
Challes-les-Eaux, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy